Literature DB >> 1551638

Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.

C Martins da Costa1, D Baldwin, B Portmann, Y Lolin, A P Mowat, G Mieli-Vergani.   

Abstract

To investigate the diagnostic value of 24-hr urinary copper excretion testing after penicillamine challenge in the diagnosis of Wilson's disease, 75 consecutive children referred for a variety of liver problems and in whom parameters of copper metabolism had been investigated were analyzed retrospectively. Seventeen had Wilson's disease, 22 had autoimmune chronic active hepatitis, 6 had primary sclerosing cholangitis, 12 had chronic liver disease of various etiologies, 4 had cryptogenic acute liver failure, 6 had acute hepatitic illnesses and 8 had a variety of disorders featuring normal liver histological appearance. Serum ceruloplasmin and total copper levels were significantly lower in Wilson's disease patients compared with all other groups, but three children with Wilson's disease had normal ceruloplasmin levels and seven had normal total copper levels. No significant difference was found for free serum copper levels and liver copper content between Wilson's disease patients and the other groups. Baseline 24-hr urinary copper excretion was significantly higher in Wilson's disease patients compared with that of the other patients, but six children with Wilson's disease had levels just above the upper limit of normal, overlapping with values obtained in three children with liver failure, two with acute hepatitis, two with autoimmune chronic active hepatitis and three with primary sclerosing cholangitis. The 24-hr urinary copper excretion after penicillamine challenge proved the most accurate single diagnostic test; levels more than 25 mumol/24 hr were present in 15 of 17 patients with Wilson's disease, but in only 1 child with liver failure of the 58 with other disorders.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551638     DOI: 10.1002/hep.1840150410

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

Review 1.  ACP Best Practice No 163. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring.

Authors:  D Gaffney; G S Fell; D S O'Reilly
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

Review 2.  Update on the Diagnosis and Management of Wilson Disease.

Authors:  Eve A Roberts
Journal:  Curr Gastroenterol Rep       Date:  2018-11-05

3.  Cholestatic liver disease masquerading as Wilson disease.

Authors:  Vikrant Sood; Dinesh Rawat; Rajeev Khanna; Seema Alam
Journal:  Indian J Gastroenterol       Date:  2015-05-05

4.  Hepatobiliary quiz-9 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-03

Review 5.  Population screening and diagnostic strategies in screening family members of Wilson's disease patients.

Authors:  Huamei Li; Ran Tao; Lifang Liu; Shiqiang Shang
Journal:  Ann Transl Med       Date:  2019-04

Review 6.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

7.  Hypertransaminasemia in childhood as a marker of genetic liver disorders.

Authors:  Raffaele Iorio; Angela Sepe; Antonietta Giannattasio; Francesco Cirillo; Angela Vegnente
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

8.  Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.

Authors:  G V Gregorio; K Choudhuri; Y Ma; P Pensati; R Iorio; P Grant; J Garson; D P Bogdanos; A Vegnente; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

9.  Fulminant hepatic failure resulting from coexistent Wilson's disease and hepatitis E.

Authors:  R Sallie; J Chiyende; K C Tan; D Bradley; B Portmann; R Williams; A P Mowat; G Mieli-Vergani
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

10.  Wilson disease: revision of diagnostic criteria in a clinical series with great genetic homogeneity.

Authors:  Luis García-Villarreal; Andrea Hernández-Ortega; Ana Sánchez-Monteagudo; Luis Peña-Quintana; Teresa Ramírez-Lorenzo; Marta Riaño; Raquel Moreno-Pérez; Alberto Monescillo; Daniel González-Santana; Ildefonso Quiñones; Almudena Sánchez-Villegas; Vicente Olmo-Quintana; Paloma Garay-Sánchez; Carmen Espinós; Jesús M González; Antonio Tugores
Journal:  J Gastroenterol       Date:  2020-11-07       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.